Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
24 February 2021 - Posted by: Francesca Miotto
On Tuesday, 26 January 2021, Allen&Overy (Belgium) LLP hosted a webinar on the key developments in parallel trade of pharmaceuticals in 2020. In this blog post, we discuss a few key topics and questions raised by the webinar’s participants. How will the competition law framework apply post-Brexit? Post-Brexit, companies active in the UK and the › Read More
22 February 2021 - Posted by: Alexis Vaujany
Given the growing number of digital tools that can be used in healthcare, the French National Authority for Health (HAS) has recently developed a system for classifying digital healthcare solutions according to their purpose of use, their capacity to provide a personalised response and their autonomy, i.e. their ability to act with or without human › Read More
27 January 2021 - Posted by: Birgit Kramer
With a decision of 19 January 2021, the Munich Regional Court (file number 21 O 16782/20) referred following question to the CJEU for a preliminary ruling: Is it compatible with Article 9 (1) of Directive 2004/48/EC that in proceedings for provisional measures the Higher Regional Courts with jurisdiction of the last instance generally refuse to › Read More
14 January 2021 - Posted by: Tine Carmeliet
Please join us on Tuesday, 26 January 2021 for a webinar on the key developments in the parallel trade of pharmaceuticals in 2020. Tine Carmeliet, Nele De Backer, Francesca Miotto, Geert Glas and Nieke Vanavermaete will talk you through recent decisions and developments in the field of parallel trade, review the impact of both Brexit › Read More
18 December 2020 - Posted by: Paul Burns
Transactions in the U.S. healthcare space rebounded in autumn, although with a greater proportion of smaller deals than in recent years. In the year to date, deal value has fallen sharply, but volume has decreased only marginally. Megadeals, common in the sector two or three years ago, are less frequent now. However, we did see › Read More